n(g)-iminoethylornithine has been researched along with sildenafil citrate in 1 studies
| Studies (n(g)-iminoethylornithine) | Trials (n(g)-iminoethylornithine) | Recent Studies (post-2010) (n(g)-iminoethylornithine) | Studies (sildenafil citrate) | Trials (sildenafil citrate) | Recent Studies (post-2010) (sildenafil citrate) |
|---|---|---|---|---|---|
| 171 | 1 | 36 | 5,862 | 956 | 2,319 |
| Protein | Taxonomy | n(g)-iminoethylornithine (IC50) | sildenafil citrate (IC50) |
|---|---|---|---|
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 0.0036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelini, GD; Jeremy, JY; Muzaffar, S; Shukla, N; Srivastava, A | 1 |
1 other study(ies) available for n(g)-iminoethylornithine and sildenafil citrate
| Article | Year |
|---|---|
Sildenafil citrate and sildenafil nitrate (NCX 911) are potent inhibitors of superoxide formation and gp91phox expression in porcine pulmonary artery endothelial cells.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Cells, Cultured; Cyclic GMP; Endothelial Cells; Guanylate Cyclase; Male; Membrane Glycoproteins; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Ornithine; Oxadiazoles; Piperazines; Protein Kinase Inhibitors; Pulmonary Artery; Purines; Quinoxalines; Sildenafil Citrate; Sulfones; Superoxides; Swine; Thionucleotides | 2005 |